A floating-type dosage form of Repaglinide (cas 108157-52-4) in polycarbonate microspheres
-
Add time:08/31/2019 Source:sciencedirect.com
ObjectiveTo prepare a floating type dosage form for the anti-diabetic drug Repaglinide (cas 108157-52-4) using polycarbonate (PC) microspheres capable of floating in the gastro-intestinal fluid to improve the biological half life and bioavailability of the drug.
We also recommend Trading Suppliers and Manufacturers of Repaglinide (cas 108157-52-4). Pls Click Website Link as below: cas 108157-52-4 suppliers
Prev:Development of Repaglinide (cas 108157-52-4) microspheres using novel acetylated starches of bitter and Chinese yams as polymers
Next:Design, synthesis and biological evaluation of novel l-lysine ureido derivatives as aminopeptidase N inhibitors) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Development of Repaglinide (cas 108157-52-4) microspheres using novel acetylated starches of bitter and Chinese yams as polymers08/30/2019
- Dual crosslinked pectin–alginate network as sustained release hydrophilic matrix for Repaglinide (cas 108157-52-4)08/29/2019
- The first insight into the supramolecular structures of popular drug Repaglinide (cas 108157-52-4): Focus on intermolecular interactions in antidiabetic agents08/28/2019
- Conformation of Repaglinide (cas 108157-52-4): A solvent dependent structure08/27/2019
- Repaglinide (cas 108157-52-4)☆08/26/2019
- Conformational flexibility and packing plausibility of Repaglinide (cas 108157-52-4) polymorphs08/25/2019
- Identification of Repaglinide (cas 108157-52-4) as a therapeutic drug for glioblastoma multiforme08/24/2019
- Endocrine pharmacologyCharacteristics of Repaglinide (cas 108157-52-4) effects on insulin secretion08/23/2019
- ArticleThe Structural Basis for the Binding of Repaglinide (cas 108157-52-4) to the Pancreatic KATP Channel08/22/2019
